デフォルト表紙
市場調査レポート
商品コード
1186535

妊活サプリメントの世界市場:現状分析・予測(2022年~2028年)

Fertility Supplement Market: Current Analysis and Forecast (2022-2028)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 154 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
妊活サプリメントの世界市場:現状分析・予測(2022年~2028年)
出版日: 2022年11月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 154 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の妊活サプリメントの市場規模は、予測期間中にCAGRで約7.8%の成長が予測されています。

世界の不妊症における有病率の急増と肥満の増加は、市場の成長を促進する主な要因です。可処分所得の増加や、座りがちなライフスタイルの増加も、予測期間中の市場に好影響を及ぼしています。

当レポートでは、世界の妊活サプリメント市場について調査し、市場の収益、成分・製品・エンドユーザー・流通・地域別の市場洞察、市場力学、企業プロファイル等に関する情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法・前提条件

  • 妊活サプリメント市場の調査プロセス
  • 妊活サプリメント市場の調査手法
  • 回答者プロファイル

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 妊活サプリメント市場におけるCOVID-19の影響

第6章 妊活サプリメント市場の収益(10億米ドル)、2020年~2028年(予測)

第7章 市場洞察:成分別

  • 天然
  • 天然・合成の合成/ブレンド

第8章 市場洞察:製品別

  • カプセル
  • 錠剤
  • ソフトジェル
  • 粉体
  • 液体

第9章 市場洞察:エンドユーザー別

  • 男性
  • 女性

第10章 市場洞察:流通別

  • OTC
  • 処方

第11章 市場洞察:地域別

  • 北米
    • 米国
    • カナダ
    • その他の北米
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • その他の地域

第12章 妊活サプリメント市場:市場力学

  • 市場促進要因
  • 市場課題
  • 影響分析

第13章 妊活サプリメント市場:機会

第14章 妊活サプリメント市場:動向

第15章 需要サイド・供給サイド分析

  • 需要サイド分析
  • 供給サイド分析

第16章 バリューチェーン分析

第17章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第18章 企業プロファイル

  • Fairhaven Health
  • Coast Science
  • LENUS Pharma GesmbH
  • Orthomol
  • Vitabiotics
  • VH Nutrition LLC
  • TTK HealthCare Ltd
  • The Bird and Be Co. Inc.
  • Bionova
  • Exeltis USA, Inc.

第19章 免責事項

目次
Product Code: UMME211341

Global Fertility Supplement Market is expected to grow at a significant rate of around 7.8% during the forecast period. Fertility supplement contains nutrients, such as folic acid, fish oil, selenium, vitamin E, vitamin D, and others to enhance the fertility of the individuals. Surge in the prevalence of infertility globally and rising rates of obesity are the key drivers boosting the growth of the market. For instance, according to the World Health Organization, in 2021, there were around 48 million couples, and 186 million individuals suffering from infertility disease globally. Apart from this, an increase in disposable income and the high adoption of a sedentary lifestyle is also having a positive impact on the market during the forecast period.

Fairhaven Health; Coast Science; Lenus Pharma GesmbH; Bionova; Vitabiotics Ltd.; Orthomol; Exeltis USA, Inc.; The Bird and Be Co. Inc.; VH Nutrition LLC, and TTK HealthCare Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, tablet category to witness higher CAGR during the forecast period"

Based on product, the market is categorized into capsules, tablets, soft gels, powder, and liquids. The tablets segment is expected to grow with high CAGR rates during the forecast period. Excipients in high-quality supplements help in tablet absorption and disintegration. Although the natural coating enhances dissolution, several other factors including efficacy and quality influence absorption. These factors are expected to drive the growth of the market during the forecast period. Apart from this, the product's ease of absorption, cost-effectiveness, and disintegration are other factors propelling the growth of the market.

"Amongst end-user type, the female to hold a significant share in the market in 2020"

On the basis of end-user, the fertility supplement market is segmented into men and women. Women held the maximum share in the global market due to an increase in fertility issues among married infertile women. Moreover, companies are rapidly launching their product in the global market which is also driving the growth of the market during the forecast period. For instance, in May 2020, WellSource Nutraceuticals launched Methyl-NX to specifically address the unique design criteria to support in vitro fertilization and fertility programs. It was created to provide sufficient quantities of bioactive folate, essential B vitamins and omega-3.

"North America to hold a significant share in the market"

In 2020, North America held a significant share of the global fertility supplement market which is due to the rising population of infertile men and women. According to the data from the Centers for Disease Control and Prevention (CDC), in 2017, around 6 million women which are estimated to be around 10% of the US women population have difficulty in conceiving a child. Additionally, in the US, there were more than 15 out of every 100 adults aging 18 or more smoke, according to the CDC. Similarly, the healthcare expenditure of the U.S. is high which is another factor driving the market's growth.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Fertility Supplement Market
  • 2.2. Research Methodology of the Fertility Supplement Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE FERTILITY SUPPLEMENT MARKET

6 FERTILITY SUPPLEMENT MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY INGREDIENT

  • 7.1. Natural
  • 7.2. Synthetic/ Blend of Natural & Synthetic

8 MARKET INSIGHTS BY PRODUCT

  • 8.1. Capsules
  • 8.2. Tablets
  • 8.3. Soft Gels
  • 8.4. Powder
  • 8.5. Liquids

9 MARKET INSIGHTS BY END USER

  • 9.1. Men
  • 9.2. Women

10 MARKET INSIGHTS BY DISTRIBUTION

  • 10.1. OTC
  • 10.2. Prescribed

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 FERTILITY SUPPLEMENT MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 FERTILITY SUPPLEMENT MARKET OPPORTUNITIES

14 FERTILITY SUPPLEMENT MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

  • 18.1. Fairhaven Health
  • 18.2. Coast Science
  • 18.3. LENUS Pharma GesmbH
  • 18.4. Orthomol
  • 18.5. Vitabiotics
  • 18.6. VH Nutrition LLC
  • 18.7. TTK HealthCare Ltd
  • 18.8. The Bird and Be Co. Inc.
  • 18.9. Bionova
  • 18.10. Exeltis USA, Inc.

19 DISCLAIMER